Psychoactive drugs including combinations : = Psychoaktive Stoffe und Kombinationspräparate = Substances psychoactives et préparations combinées
- Weitere Titel
-
Psychoaktive Stoffe und Kombinationspräparate
Substances psychoactives et préparations combinées
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783805517409
3805517408
- Maße
-
31 cm
- Umfang
-
XIX, 264.;
- Sprache
-
Deutsch
- Anmerkungen
-
Literaturverz. S. 262 - 264.
- Erschienen in
-
Datenverarbeitung in der Medizin ; Vol. 3
- Schlagwort
-
Psychopharmakon
Psychopharmaka
Psychopharmakon
- Ereignis
-
Veröffentlichung
- (wo)
-
Basel, München, Paris, London, New York, Sydney
- (wer)
-
Karger
- (wann)
-
1974
- Urheber
-
Wider, François
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wider, François
- Karger
Entstanden
- 1974
Ähnliche Objekte (12)
Release adjustment of drug combinations with different drug solubility
Release adjustment of drug combinations with different drug solubility
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
Cell physiology based pharmacodynamic modeling of antimicrobial drug combinations
NOXA as critical mediator for drug combinations in polychemotherapy
Systematic identification of rational drug combinations in chronic lymphocytic leukemia
Influence of neuroimplant materials, drugs and drug-material combinations on healthy cells of the brain
Systematic identification of rational drug combinations in Burkitt lymphoma cell lines
No. V. Quantity of certain important Drugs contained in different Preparations.
Legalisation and Decriminalisation of Narcotic Drugs and Psychotropic Substances
Environmental risk assessment of pharmaceutical drug substances - conceptual considerations
Combinations-Linien.
Release adjustment of drug combinations with different drug solubility
Release adjustment of drug combinations with different drug solubility
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
Cell physiology based pharmacodynamic modeling of antimicrobial drug combinations
NOXA as critical mediator for drug combinations in polychemotherapy
Systematic identification of rational drug combinations in chronic lymphocytic leukemia
Influence of neuroimplant materials, drugs and drug-material combinations on healthy cells of the brain
Systematic identification of rational drug combinations in Burkitt lymphoma cell lines
No. V. Quantity of certain important Drugs contained in different Preparations.
Legalisation and Decriminalisation of Narcotic Drugs and Psychotropic Substances
Environmental risk assessment of pharmaceutical drug substances - conceptual considerations
Combinations-Linien.
Release adjustment of drug combinations with different drug solubility
Release adjustment of drug combinations with different drug solubility
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
Cell physiology based pharmacodynamic modeling of antimicrobial drug combinations
NOXA as critical mediator for drug combinations in polychemotherapy
Systematic identification of rational drug combinations in chronic lymphocytic leukemia
Influence of neuroimplant materials, drugs and drug-material combinations on healthy cells of the brain
Systematic identification of rational drug combinations in Burkitt lymphoma cell lines
No. V. Quantity of certain important Drugs contained in different Preparations.
Legalisation and Decriminalisation of Narcotic Drugs and Psychotropic Substances
Environmental risk assessment of pharmaceutical drug substances - conceptual considerations